SKI Market

A+| A| A-|

Indian Indices

Sensex

79,273.33 753.03
( 0.96%)

Global Indices

Nasdaq

49,166.17 -297.40
(-0.60%)

Dow Jones

7,084.21 -45.93
(-0.64%)

Hang Seng

59,361.39 536.50
(0.91%)

Nikkei 225

10,503.87 -105.21
(-0.99%)

Forex

USD-INR

92.58 -0.61
(-0.65%)

EUR-INR

108.87 -0.98
(-0.89%)

GBP-INR

125.07 -1.17
(-0.93%)

JPY-INR

0.58 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Eiko Lifesciences Ltd

Industry : Chemicals

BSE Code

ISIN Demat

Book Value()

540204

INE666Q01016

42.7795752

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

23.67

73.34

EPS(TTM)

Face Value()

Div & Yield %

2.16

Back

Venus Remedies consolidated net profit rises 30.51% in the December 2025 quarter

Jan 30,2026

Net profit of Venus Remedies rose 30.51% to Rs 25.58 crore in the quarter ended December 2025 as against Rs 19.60 crore during the previous quarter ended December 2024. Sales rose 2.12% to Rs 180.26 crore in the quarter ended December 2025 as against Rs 176.52 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	180.26	176.52	2
OPM %	20.81	10.21	-
PBDT	40.03	20.38	96
PBT	33.47	14.97	124
NP	25.58	19.60	31

79,273.33 753.03 ( 0.96%)

49,166.17 -297.40 (-0.60%)

7,084.21 -45.93 (-0.64%)

59,361.39 536.50 (0.91%)

10,503.87 -105.21 (-0.99%)

92.58 -0.61 (-0.65%)

108.87 -0.98 (-0.89%)

125.07 -1.17 (-0.93%)

0.58 0.00 (-0.45%)